Journal
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 16, Issue 5, Pages 533-550Publisher
SHENYANG PHARMACEUTICAL UNIV
DOI: 10.1016/j.ajps.2021.02.006
Keywords
Non coding rnas; Alzheimer's disease; Huntington's disease; Parkinson's disease; Schizophrenia; Regulatory
Categories
Ask authors/readers for more resources
Long non coding RNAs (lncRNAs) play crucial roles in neurological disorders, participating in pathogenesis through various mechanisms, and can serve as potential biomarkers and therapeutic targets.
Long non coding RNAs (lncRNAs) are non-protein or low-protein coding transcripts that contain more than 200 nucleotides. They representing a large share of the cell's transcriptional output, demonstrate functional attributes viz. tissue-specific expression, determination of cell fate, controlled expression, RNA processing and editing, dosage compensation, genomic imprinting, conserved evolutionary traits etc. These long non coding variants are well associated with pathogenicity of various diseases including the neurological disorders like Alzheimer's disease, schizophrenia, Huntington's disease, Parkinson's disease etc. Neurological disorders are widespread and there knowing the underlying mechanisms become crucial. The lncRNAs take part in the pathogenesis by a plethora of mechanisms like decoy, scaffold, mi-RNA sequestrator, histone modifiers and in transcriptional interference. Detailed knowledge of the role of lncRNAs can help to use them further as novel biomarkers for therapeutic aspects. Here, in this review we discuss regulation and functional roles of lncRNAs in eight neurological diseases and psychiatric disorders, and the mechanisms by which they act. With these, we try to establish their roles as potential markers and viable diagnostic tools in these disorders. (C) 2021 Shenyang Pharmaceutical University. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available